How 2,000 Tons Of Sand Stores 100 Megawatt-Hours And Slashes Carbon Emissions 70%

The world’s largest sand battery stores heat, then releases it on demand. But it’s about to lose its title as the world’s largest …

3 Questions To Reveal Your ‘Emotional Age’ In Love, By A Psychologist

Your chronological age tells you how long you’ve been alive. Your emotional age questions how many of those years you have spent working on your relationships.

SNIA MRAM Alliance Targeting $171B New Memory Market

SNIA announces the MRAM Alliance Special Interest Group to support a developing ecosystem for MRAM memory for many consumer, industrial and data center applications.

Apple’s Hidden Strength In The Rush To Wide Foldable Smartphones

Smartphone designers know what’s coming in 2026: wide foldable phones. That comes with software complications and one company is best placed to deal with this challenge.

AI Canvases Move From Collaboration To Core Revenue And IT Operations

AI canvases now touch more core operations, not just collaboration. The upsides are clear, but good governance is vital to manage AI actions across enterprise platforms.

New Samsung Galaxy Price Shock Is Bad News For 2026 Buyers

A new Samsung Galaxy price shock is destroying the wait and save rule. This is bad news for millions of Android buyers in 2026.

Why Data Is Becoming The New Executive Language

Data has become the core language of leadership, enabling faster decisions, sharper strategy, deeper customer insight, and greater efficiency in modern organizations.

Robinhood And Coinbase Stocks Rally As Prediction Markets Could Grow To $1 Trillion

Robinhood and Coinbase will be winners in the prediction market boom, analysts say.

Why Structured Data May Be AI’s Next Enterprise Frontier

Enterprise AI startup Kumo is making the case that the next phase of enterprise AI will be shaped by structured and relational data.

New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.